Works matching DE "EPOETIN alfa (Drug)"
Results: 62
The impact of hyporesponsiveness to erythropoietin-stimulating agents on time-dependent mortality risk among CKD stage 5D patients: a single-center cohort study.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 1, p. 106, doi. 10.1007/s10157-012-0659-6
- By:
- Publication type:
- Article
Epoetin alfa reduces anemia in breast cancer patients with no negative impact on survival.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 14, p. 1, doi. 10.1093/jnci/djt208
- Publication type:
- Article
Erythropoiesis Stimulating Agents: A Personal Journey.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
Epoetin Alfa: To Give or Not to Give.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Intravenous iron and erythropoiesis-stimulating agents in haemodialysis: A systematic review and meta-analysis.
- Published in:
- Nephrology, 2017, v. 22, n. 12, p. 969, doi. 10.1111/nep.12940
- By:
- Publication type:
- Article
Association between responsiveness to methoxy polyethylene glycol-epoetin beta and renal survival in patients with non-dialysis-dependent chronic kidney disease: A pooled analysis of individual patient-level data from clinical trials.
- Published in:
- Nephrology, 2017, v. 22, n. 10, p. 769, doi. 10.1111/nep.12842
- By:
- Publication type:
- Article
Biosimilar Epoetin Zeta in Oncology and Haematology: Development and Experience following 6 Years of Use.
- Published in:
- Acta Haematologica, 2015, v. 135, n. 1, p. 44, doi. 10.1159/000438976
- By:
- Publication type:
- Article
Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis.
- Published in:
- Intensive Care Medicine, 2013, v. 39, n. 11, p. 1896, doi. 10.1007/s00134-013-3030-9
- By:
- Publication type:
- Article
Characterization of N-glycan heterogeneities of erythropoietin products by liquid chromatography/mass spectrometry and multivariate analysis.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2014, v. 28, n. 8, p. 921, doi. 10.1002/rcm.6858
- By:
- Publication type:
- Article
Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 8, p. 1413, doi. 10.1007/s00277-014-2053-9
- By:
- Publication type:
- Article
The COPD Pipeline XVII.
- Published in:
- COPD: Journal of Chronic Obstructive Pulmonary Disease, 2012, v. 9, n. 4, p. 432, doi. 10.3109/15412555.2012.702003
- By:
- Publication type:
- Article
Epoetin beta pegol alleviates oxidative stress and exacerbation of renal damage from iron deposition, thereby delaying CKD progression in progressive glomerulonephritis rats.
- Published in:
- Physiological Reports, 2015, v. 3, n. 12, p. n/a, doi. 10.14814/phy2.12637
- By:
- Publication type:
- Article
Anaphylactic Shock at the End of Hemodialysis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Epoetin Alfa: A Cause of Coronary Artery Thrombosis.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) Program.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Long Term Effects of Epoetin Alfa in Patients with ST- Elevation Myocardial Infarction.
- Published in:
- Cardiovascular Drugs & Therapy, 2013, v. 27, n. 5, p. 433, doi. 10.1007/s10557-013-6470-0
- By:
- Publication type:
- Article
Biosimilar competition: lessons from Europe.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 2, p. 99, doi. 10.1038/nrd4210
- By:
- Publication type:
- Article
Anaemia of renal disease: pathophysiology and treatment updates.
- Published in:
- UK-Vet Companion Animal, 2015, v. 20, n. 8, p. 448, doi. 10.12968/coan.2015.20.8.448
- By:
- Publication type:
- Article
Biosimilars: Challenges and path forward.
- Published in:
- Biotechnology & Bioprocess Engineering, 2014, v. 19, n. 5, p. 755, doi. 10.1007/s12257-013-0756-8
- By:
- Publication type:
- Article
Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 6689, doi. 10.2147/OTT.S104743
- By:
- Publication type:
- Article
Pure red cell aplasia induced by epoetin zeta.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Results From the EPO-ANE-3010 Study Consistent With US Black Box Labeling.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 12, doi. 10.1177/1559897715571063
- By:
- Publication type:
- Article
Human choriogonadotropin and epoetin alfa in acute ischemic stroke patients ( REGENESIS-LED trial).
- Published in:
- International Journal of Stroke, 2014, v. 9, n. 3, p. 321, doi. 10.1111/ijs.12260
- By:
- Publication type:
- Article
Biosimilar epoetin α is as effective as originator epoetin-α plus liposomal iron (Sideral®), vitamin B12 and folates in patients with refractory anemia: A retrospective real-life approach.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 4, p. 41, doi. 10.3892/mco.2015.555
- By:
- Publication type:
- Article
Effect of occasional epoetin use in combination with a stable darbepoetin dosage on anemia management in hemodialysis patients.
- Published in:
- ClinicoEconomics & Outcomes Research, 2014, v. 6, p. 531, doi. 10.2147/CEOR.S73473
- By:
- Publication type:
- Article
Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease.
- Published in:
- Hippokratia, 2014, v. 18, n. 4, p. 315
- By:
- Publication type:
- Article
A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 4, p. 717, doi. 10.1007/s00432-016-2339-5
- By:
- Publication type:
- Article
Development and exploitation of a clinical decision support system for the management of renal anaemia.
- Published in:
- Nephrology Dialysis Transplantation, 2007, v. 22, n. suppl_4, p. iv31, doi. 10.1093/ndt/gfm163
- By:
- Publication type:
- Article
Pharmacology of darbepoetin alfa.
- Published in:
- Nephrology Dialysis Transplantation, 2007, v. 22, n. suppl_4, p. iv2, doi. 10.1093/ndt/gfm160
- By:
- Publication type:
- Article
Switch from epoetin to darbepoetin alfa in hemodialysis: dose equivalence and hemoglobin stability.
- Published in:
- International Journal of Nephrology & Renovascular Disease, 2014, v. 7, p. 353, doi. 10.2147/IJNRD.S61895
- By:
- Publication type:
- Article
Treatment of confirmed B12 deficiency in hemodialysis patients improves Epogen® requirements.
- Published in:
- International Journal of Nephrology & Renovascular Disease, 2013, v. 6, p. 89, doi. 10.2147/IJNRD.S44660
- By:
- Publication type:
- Article
Effect of hepatitis C virus infection on erythropoiesis in patients on hemodialysis.
- Published in:
- International Journal of Nephrology & Renovascular Disease, 2013, v. 6, p. 121, doi. 10.2147/IJNRD.S44656
- By:
- Publication type:
- Article
BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-503
- By:
- Publication type:
- Article
Synchronization of administrations of chemotherapy and erythropoiesis-stimulating agents and frequency of associated healthcare visits.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 11, p. 2957, doi. 10.1007/s00520-013-1830-7
- By:
- Publication type:
- Article
Effects of Crit-Line® Monitor Use on Patient Outcomes and Epoetin Alfa Dosing following Onset of Hemodialysis: A Propensity Score-Matched Study.
- Published in:
- Blood Purification, 2014, v. 37, n. 3, p. 249, doi. 10.1159/000362107
- By:
- Publication type:
- Article
Erythropoietin Resistance Index and the All-Cause Mortality of Chronic Hemodialysis Patients.
- Published in:
- Blood Purification, 2014, v. 37, n. 2, p. 106, doi. 10.1159/000358215
- By:
- Publication type:
- Article
Conversion from Epoetin and Darbepoetin to C.E.R.A. in Non-Dialysis CKD Patients: A Multicenter Italian Prospective Study in Nephrology Practice.
- Published in:
- Blood Purification, 2013, v. 36, n. 2, p. 69, doi. 10.1159/000353607
- By:
- Publication type:
- Article
Iron Status, Iron and Epoetin Therapy in Chronic Hemodialysis Patients-A Single Center Experience.
- Published in:
- BANTAO Journal, 2013, v. 11, n. 2, p. 65
- By:
- Publication type:
- Article
Waldenstrom macroglobulinemia with a durable clinical response to epoetin beta.
- Published in:
- Leukemia & Lymphoma, 2012, v. 53, n. 9, p. 1811, doi. 10.3109/10428194.2012.658795
- By:
- Publication type:
- Article
Epoetin β pegol (continuous erythropoietin receptor activator, CERA) is another choice for the treatment of anemia in myelodysplastic syndrome: a case report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Epoetin-β induced pure red cell aplasia: an unintended consequence.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Optimizing the management of renal anemia: challenges and new opportunities: New strategies to prevent cardiovascular risk in chronic kidney disease.
- Published in:
- Kidney International, 2008, v. 74, p. S33, doi. 10.1038/ki.2008.525
- By:
- Publication type:
- Article
Detection of EPO injections using a rapid lateral flow isoform test.
- Published in:
- Analytical & Bioanalytical Chemistry, 2013, v. 405, n. 30, p. 9685, doi. 10.1007/s00216-013-6997-8
- By:
- Publication type:
- Article
Risk of venous thromboembolism in cancer patients treated with epoetins or blood transfusions.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 3, p. 839, doi. 10.1111/bcp.13019
- By:
- Publication type:
- Article
Japanese regulation of biosimilar products: past experience and current challenges.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 1, p. 30, doi. 10.1111/bcp.12931
- By:
- Publication type:
- Article
A Comparative Study of the Hemoglobin-Maintaining Effects Between Epoetin-β Pegol and Darbepoetin-α in Patients with Chronic Kidney Disease During 3 Months Before Dialysis Initiation.
- Published in:
- Drugs in R&D, 2017, v. 17, n. 3, p. 389, doi. 10.1007/s40268-017-0188-6
- By:
- Publication type:
- Article
The Use of Epoetin-α in Revision Knee Arthroplasty.
- Published in:
- Advances in Orthopedics, 2012, p. 1, doi. 10.1155/2012/595027
- By:
- Publication type:
- Article